Overview
GammaDelta Therapeutics Limited is a UK headquartered biotechnology. The company was founded on the basis of world-class academic research conducted at King’s College London and the Francis Crick Institute.
GammaDelta Therapeutics aims to harness the unique properties of a subset of γδ T cells to improve patient outcomes and survival rates among patients with certain haematological malignancies and solid tumours.
Douglass Digital was approached by GammaDelta Therapeutics to provide a brand new website that was more dynamic, simpler to update, manage and with an enhanced visual appearance.
Our Solution
Douglass Digital worked with GammaDelta Therapeutics on a full re-design of the website to accommodate GammaDelta Therapeutics’ newly crafted content, graphics and animations.
As part of this project Douglass Digital provided GammaDelta Therapeutics with a hero video of the lab space demonstrating the working environment. Douglass Digital also worked with GammaDelta Therapeutics on integrating their 3D animation seamlessly into the design of the website.
The new WordPress website needed to display scientific information in an engaging way, including effective videos and animations that are seamlessly integrated into the design of the new website.
Douglass Digital have provided highly dedicated and skilled support to us with both with a significant redesign and development of our website and content, which has been scaled and upgraded with the development and evolution of our business, in addition to on-going support and maintenance of our web presence. The core project was developed and managed by Douglass Digital to achieve a high quality and professional result working to coordinate both external content writers and graphic designers alongside our internal review team. The Douglass Digital team were highly engaged and diligent in working to coordinate and turn around the design phase to achieve our launch date and continue to support us in maintaining and further enhancing the content of our website based on our developing business needs
